AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 30 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $41,000 | +24.2% | 58,000 | +16.0% | 0.00% | – |
| Q3 2016 | $33,000 | -23.3% | 50,000 | -33.3% | 0.00% | – |
| Q2 2016 | $43,000 | +13.2% | 75,000 | 0.0% | 0.00% | – |
| Q1 2016 | $38,000 | -24.0% | 75,000 | 0.0% | 0.00% | – |
| Q4 2015 | $50,000 | -10.7% | 75,000 | 0.0% | 0.00% | – |
| Q3 2015 | $56,000 | – | 75,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 1,760,000 | $898,000 | 1.12% |
| Telemetry Investments, L.L.C. | 6,000,000 | $3,049,000 | 0.89% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 54,500,000 | $27,693,000 | 0.46% |
| ZAZOVE ASSOCIATES LLC | 15,070,000 | $7,761,000 | 0.37% |
| ACUTA CAPITAL PARTNERS, LLC | 1,000,000 | $508,000 | 0.28% |
| Tekla Capital Management LLC | 13,000,000 | $6,606,000 | 0.28% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,000,000 | $13,910,000,000 | 0.26% |
| Castle Creek Arbitrage, LLC | 4,000,000 | $2,081,000 | 0.17% |
| WOLVERINE ASSET MANAGEMENT LLC | 10,934,000 | $5,558,000 | 0.16% |
| Baker Brothers Advisors | 26,517,000 | $13,526,000 | 0.14% |